BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gautier M, Normand AC, L'Ollivier C, Cassagne C, Reynaud-Gaubert M, Dubus JC, Brégeon F, Hendrickx M, Gomez C, Ranque S, Piarroux R. Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease. Med Mycol 2016;54:459-70. [PMID: 26773134 DOI: 10.1093/mmy/myv118] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ojuri OT, Ezekiel CN, Sulyok M, Ezeokoli OT, Oyedele OA, Ayeni KI, Eskola MK, Šarkanj B, Hajšlová J, Adeleke RA, Nwangburuka CC, Elliott CT, Krska R. Assessing the mycotoxicological risk from consumption of complementary foods by infants and young children in Nigeria. Food and Chemical Toxicology 2018;121:37-50. [DOI: 10.1016/j.fct.2018.08.025] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
2 Wardlaw AJ, Rick EM, Pur Ozyigit L, Scadding A, Gaillard EA, Pashley CH. New Perspectives in the Diagnosis and Management of Allergic Fungal Airway Disease. J Asthma Allergy 2021;14:557-73. [PMID: 34079294 DOI: 10.2147/JAA.S251709] [Reference Citation Analysis]
3 Rick EM, Woolnough KF, Seear PJ, Fairs A, Satchwell J, Richardson M, Monteiro WR, Craner M, Bourne M, Wardlaw AJ, Pashley CH. The airway fungal microbiome in asthma. Clin Exp Allergy 2020;50:1325-41. [PMID: 32808353 DOI: 10.1111/cea.13722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Imbert S, Normand AC, Gabriel F, Cassaing S, Bonnal C, Costa D, Lachaud L, Hasseine L, Kristensen L, Schuttler C, Raberin H, Brun S, Hendrickx M, Stubbe D, Piarroux R, Fekkar A. Multi-centric evaluation of the online MSI platform for the identification of cryptic and rare species of Aspergillus by MALDI-TOF. Medical Mycology 2019;57:962-8. [DOI: 10.1093/mmy/myz004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
5 Szmigiel K, Nentwig M, Oeckler O, Barczyńska-felusiak R, Morzyk-ociepa B. Crystal structure, vibrational spectroscopic characterization, thermal behavior and antifungal activity of a novel coordination polymer of indole‑3‑carboxylic acid with cobalt(II) and a comparison with the isostructural Zn(II) complex. Inorganic Chemistry Communications 2018;97:56-62. [DOI: 10.1016/j.inoche.2018.09.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Xu D, Lin SR, Bonelli L, Glasgow BJ, Goldberg RA. Orbital granulomatosis with polyangiitis masquerading as invasive fungal sinusitis. Orbit 2018;37:309-12. [DOI: 10.1080/01676830.2017.1423339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Ban S, Kasaishi R, Kamijo T, Noritake C, Kawasaki H. An exploratory MALDI-TOF MS library based on SARAMIS superspectra for rapid identification of <i>Aspergillus</i> section <i>Nigri</i>. Mycoscience 2021;62:224-32. [DOI: 10.47371/mycosci.2021.03.004] [Reference Citation Analysis]
8 Chotirmall SH, Martin-gomez MT. Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways. Mycopathologia 2018;183:45-59. [DOI: 10.1007/s11046-017-0143-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
9 Hashimoto A, Hagiwara D, Watanabe A, Yahiro M, Yikelamu A, Yaguchi T, Kamei K. Drug Sensitivity and Resistance Mechanism in Aspergillus Section Nigri Strains from Japan. Antimicrob Agents Chemother 2017;61:e02583-16. [PMID: 28607016 DOI: 10.1128/AAC.02583-16] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
10 Zanganeh E, Zarrinfar H, Rezaeetalab F, Fata A, Tohidi M, Najafzadeh MJ, Alizadeh M, Seyedmousavi S. Predominance of non-fumigatus Aspergillus species among patients suspected to pulmonary aspergillosis in a tropical and subtropical region of the Middle East. Microbial Pathogenesis 2018;116:296-300. [DOI: 10.1016/j.micpath.2018.01.047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
11 Nabet C, Imbert S, Normand AC, Blanchet D, Chanlin R, Becker P, Demar M, Piarroux R. Unexpected mould diversity in clinical isolates from French Guiana and associated identification difficulties. Med Mycol 2020:myaa091. [PMID: 33111143 DOI: 10.1093/mmy/myaa091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Frías-de-león M, Rosas-de Paz E, Arenas R, Atoche C, Duarte-escalante E, Molina de Soschin D, Acosta-altamirano G, Reyes-montes M. Identification of Aspergillus tubingensis in a primary skin infection. Journal de Mycologie Médicale 2018;28:274-8. [DOI: 10.1016/j.mycmed.2018.02.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Sabz G, Gharaghani M, Mirhendi H, Ahmadi B, Gatee MA, Sisakht MT, Hemati A, Mohammadi R, Taghavi J, Nouripour-Sisakht S. Clinical and microbial epidemiology of otomycosis in the city of Yasuj, southwest Iran, revealing Aspergillus tubingensis as the dominant causative agent. J Med Microbiol 2019;68:585-90. [PMID: 30801244 DOI: 10.1099/jmm.0.000948] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
14 Salah H, Lackner M, Houbraken J, Theelen B, Lass-Flörl C, Boekhout T, Almaslamani M, Taj-Aldeen SJ. The Emergence of Rare Clinical Aspergillus Species in Qatar: Molecular Characterization and Antifungal Susceptibility Profiles. Front Microbiol 2019;10:1677. [PMID: 31447794 DOI: 10.3389/fmicb.2019.01677] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Iatta R, Nuccio F, Immediato D, Mosca A, De Carlo C, Miragliotta G, Parisi A, Crescenzo G, Otranto D, Cafarchia C. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings. J Clin Microbiol 2016;54:2365-72. [PMID: 27413191 DOI: 10.1128/JCM.01075-16] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
16 Carrara B, Richards R, Imbert S, Morio F, Sasso M, Zahr N, Normand AC, Le Pape P, Lachaud L, Ranque S, Maubon D, Piarroux R, Fekkar A. Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112 Aspergillus Section Nigri Isolates. Antimicrob Agents Chemother 2020;64:e02510-19. [PMID: 32312779 DOI: 10.1128/AAC.02510-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
17 [DOI: 10.1101/541185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Buil JB, Rijs AJMM, Meis JF, Birch M, Law D, Melchers WJG, Verweij PE. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates. J Antimicrob Chemother 2017;72:2548-52. [PMID: 28605488 DOI: 10.1093/jac/dkx177] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 11.3] [Reference Citation Analysis]
19 Amanati A, Lotfi M, Masoudi MS, Jafarian H, Ghasemi F, Bozorgi H, Badiee P. Cerebral and pulmonary aspergillosis, treatment and diagnostic challenges of mixed breakthrough invasive fungal infections: case report study. BMC Infect Dis 2020;20:535. [PMID: 32703183 DOI: 10.1186/s12879-020-05162-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
20 Al-yasiri MH, Normand A, Mauffrey J, Ranque S. Anthropogenic impact on environmental filamentous fungi communities along the Mediterranean littoral. Mycoses 2017;60:477-84. [DOI: 10.1111/myc.12612] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Jaggi TK, Ter SK, Mac Aogáin M, Chotirmall SH. Aspergillus-Associated Endophenotypes in Bronchiectasis. Semin Respir Crit Care Med 2021;42:556-66. [PMID: 34261180 DOI: 10.1055/s-0041-1730947] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Najafzadeh MJ, Dolatabadi S, Zarrinfar H, Houbraken J. Molecular Diversity of Aspergilli in Two Iranian Hospitals. Mycopathologia 2021;186:519-33. [PMID: 34052941 DOI: 10.1007/s11046-021-00563-z] [Reference Citation Analysis]
23 Guo MJ, Wang QT, Cheng YH, Hou CL. Identification of Aspergillus tubingensis causing pomegranate fruit rot in China. Australasian Plant Pathol 2021;50:233-40. [DOI: 10.1007/s13313-020-00769-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Gautier M, Normand AC, Ranque S. Previously unknown species of Aspergillus. Clin Microbiol Infect 2016;22:662-9. [PMID: 27263029 DOI: 10.1016/j.cmi.2016.05.013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
25 Hagiwara S, Tamura T, Satoh K, Kamewada H, Nakano M, Shinden S, Yamaguchi H, Makimura K. The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan. Mycopathologia 2019;184:13-21. [PMID: 30291485 DOI: 10.1007/s11046-018-0299-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
26 Castro C, Galán-Sanchez F, Linares MJ, Tejero R, Ruiz M, Serrano ML, Rodríguez-Iglesias M, Martín-Mazuelos E; FUNGAE-IFI Study Group. A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns. Med Mycol 2019;57:412-20. [PMID: 30289467 DOI: 10.1093/mmy/myy080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 Singh A, Ralhan A, Schwarz C, Hartl D, Hector A. Fungal Pathogens in CF Airways: Leave or Treat? Mycopathologia 2018;183:119-37. [PMID: 28770417 DOI: 10.1007/s11046-017-0184-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
28 Hagiwara D, Watanabe A, Kamei K, Goldman GH. Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Fungi. Front Microbiol 2016;7:1382. [PMID: 27708619 DOI: 10.3389/fmicb.2016.01382] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 14.7] [Reference Citation Analysis]
29 Lass-Flörl C, Cuenca-Estrella M. Changes in the epidemiological landscape of invasive mould infections and disease. J Antimicrob Chemother 2017;72:i5-i11. [PMID: 28355462 DOI: 10.1093/jac/dkx028] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
30 Takeda K, Suzuki J, Watanabe A, Matsuki M, Higa K, Inoue E, Akashi S, Shimada M, Kawashima M, Ohshima N, Fukami T, Masuda K, Yamane A, Tamura A, Nagai H, Matsui H, Tohma S, Kamei K. Species identification, antifungal susceptibility, and clinical feature association of Aspergillus section Nigri isolates from the lower respiratory tract. Med Mycol 2020;58:310-4. [PMID: 31240316 DOI: 10.1093/mmy/myz072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]